insulin - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection 10mL vial AUST R: 39656 Active ingredients: insulin Dosage form: Injection, suspension Sponsor: Eli Lilly Australia Pty Ltd Phone: 1800454559	From 23 Oct 2023 to 30 Apr 2024	Shortage status: Current Availability: Unavailable Reason: Manufacturing Management action: Alternative generic products are available.
MIXTARD 30/70 INNOLET human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169628 Active ingredients: insulin Dosage form: Injection, suspension Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd Phone: 1800 668 626	Deletion from market: 31 Jul 2024	Shortage status: To be discontinued Availability: Unavailable Reason: Commercial Changes / Commercial viability
MIXTARD 30/70 PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169629 Active ingredients: insulin Dosage form: Injection, suspension Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd Phone: 1800 668 626	Deletion from market: 01 Feb 2025	Shortage status: To be discontinued Availability: Unavailable Reason: Commercial Changes / Commercial viability Management action: Alternative brand available
MIXTARD 50/50 PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169630 Active ingredients: insulin Dosage form: Injection, suspension Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd Phone: 1800 668 626	Deletion from market: 31 May 2023	Shortage status: Discontinued Availability: Unavailable Reason: Commercial Changes / Commercial viability Management action: Other strengths are available.